ArticleMedicina (Kaunas, Lithuania)2022

Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients.

Ingrida Stankute et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.